ISO 10993 certification of medical polymer splint polyurethane substrate tri(dimethylaminopropyl)hexahydrotriazine

Date：2025-03-19 Categories：Our Projects

ISO 10993 certification for medical polymer splint polyurethane substrate tri(dimethylaminopropyl)hexahydrotriazine

Preface: Entering the world of medical polymer splints

In the medical field, medical polymer materials have become an important part of modern medical devices due to their excellent performance and versatility. Among them, medical polymer splint made of polyurethane as the base material and added functional additives has attracted much attention. This splint not only has the advantages of lightness, breathability, waterproofness, etc., but can also be customized according to the specific needs of the patient, greatly improving the patient’s comfort and rehabilitation efficiency. However, any medical product must pass a series of strict biocompatibility tests and international standards for entry into the market and application in clinical practice. ISO 10993 is one of the authoritative certification systems in this field.

Today, we will focus on a special medical polymer splint – a product that uses polyurethane as the substrate and contains functional additives of tri(dimethylaminopropyl)hexahydrotriazine (TDMHAT for short). This plywood not only has the advantages of traditional polymer plywood, but also performs excellently in antibacterial properties, durability and mechanical strength. But does its safety and effectiveness comply with the standards of ISO 10993? How does it perform in practical applications? Next, let’s explore these issues in depth and uncover the mystery of this medical polymer splint.

Basic principles and application scenarios of medical polymer splint

Medical polymer splint is a medical device made of high-performance polymer materials. It is mainly used to fix fractured areas or support injured limbs to help patients recover their functions. Its core principle is to utilize the mechanical properties and plasticity of polymer materials to provide patients with a comfortable experience while maintaining stability. Compared with traditional gypsum plywood, medical polymer plywood has the following significant advantages:

Lightweight Design: The weight of polymer splints is usually only half or even lower than that of gypsum splints, greatly reducing the burden on patients.
Good breathability: Polymer materials allow air circulation, reducing discomfort caused by long-term closure.
Waterproofing: Patients can bathe normally or contact water with splints without additional protection.
Easy to adjust: Doctors can cut or reshape the splint according to the specific situation of the patient to achieve accurate adaptation.

Among these characteristics, the role of polyurethane as a substrate material is particularly important. Polyurethane (PU) is a polymer compound produced by the reaction of polyols and isocyanates, with its excellenceIt is known for its flexibility, wear resistance and biocompatibility. By introducing functional additives such as tris(dimethylaminopropyl)hexahydrotriazine (TDMHAT), the antibacterial properties and chemical stability of the splint can be further improved, making it more suitable for complex medical environments.

Application Scenarios

Medical polymer splints are widely used in orthopedics, trauma surgery and rehabilitation medicine, including but not limited to the following scenarios:

Fracture Fixation: Used for fracture fixation in the arms, legs, or other parts to ensure that the bones remain in the correct position during healing.
Joint Support: Assist in the treatment of sprains, strains and other soft tissue injuries, while protecting the joints from secondary damage.
Postoperative Care: Provide additional support for patients after surgery, promote wound healing and shorten recovery time.
Sports Injury Protection: Athletes use splints during training or competition to prevent accidental injuries.

It can be said that medical polymer splints have become an indispensable part of the modern medical system. However, to ensure its safety and effectiveness, all related products must undergo rigorous testing and certification. This is exactly what the ISO 10993 standard means.

Overview of ISO 10993 Standard

ISO 10993 is an international set of standards specifically for the biocompatibility of medical devices, aiming to evaluate the safety of medical devices in the human body or on the surface. This set of standards covers multiple aspects from cytotoxicity to systemic toxicity, ensuring that every medical device can play its due role without damaging health. For medical polymer splints, the certification process of ISO 10993 is particularly important because it is directly related to the safety and reliability of the product.

The following are the main contents of ISO 10993 and its application in the certification of medical polymer splints:

Test items	Description	Related Terms
Cytotoxicity test	Detection whether the material will have a toxic effect on cells, such as inhibiting cell growth or causing cell death.	ISO 10993-5
Sensitivity Test	Determine whether the material can cause allergic reactions, especially the potential risks of long-term skin contact.	ISO 10993-10
Stimulus test	Inspect the degree of irritation of the material on the skin or mucosa to avoid symptoms such as redness, swelling, and itching.	ISO 10993-10
Hemocompatibility test	Analyze the reaction of the material when it comes into contact with blood to prevent the occurrence of coagulation or hemolysis.	ISO 10993-4
Acute systemic toxicity test	Simulate whether the material will have a toxic effect on the entire body under short-term exposure conditions.	ISO 10993-11
Chronic toxicity test	After long-term use, will the material cause cumulative damage to the body?	ISO 10993-11
Carcogenicity Test	Troubleshooting materials for carcinogenic risks, especially when they may be degraded or release harmful substances.	ISO 10993-3
Reproductive toxicity test	Check whether the material affects reproductive system function or fetal development.	ISO 10993-11

Through the above tests, ISO 10993 can comprehensively evaluate the safety of medical polymer splints, thereby providing patients with reliable protection. Next, we will focus on analyzing the special role of tri(dimethylaminopropyl)hexahydrotriazine in this certification process.

The mechanism and advantages of tris(dimethylaminopropyl)hexahydrotriazine

Tri(dimethylaminopropyl)hexahydrotriazine (TDMHAT) is a multifunctional organic compound that is often used as an antibacterial agent, crosslinking agent and stabilizer. In medical polymer splints, the main functions of TDMHAT can be summarized into the following aspects:

1. Enhanced antibacterial performance

TDMHAT molecules contain multiple active functional groups, which can bind to the bacterial surface through electrostatic action or covalent bonds, destroying their cell membrane structure, thereby achieving bactericidal effect. Studies have shown that medical polymer splints containing TDMHAT have significant inhibitory effects on many common pathogenic microorganisms such as Staphylococcus aureus and E. coli.

2. Improve chemical stability

TDMHAT can also form a crosslinking network with other polymer chains, enhancing the overall structural strength and durability of the splint. This crosslinking effect not only extends the service life of the splint, but also effectively prevents external environmental factors (such as ultraviolet rays, humidity, etc.)damage caused to it.

3. Improve processing performance

In the production process, TDMHAT, as a high-efficiency catalyst, can accelerate the curing reaction of polyurethane, improve production efficiency and reduce energy consumption. In addition, it can give the splint better flexibility and plasticity, allowing doctors to make precise adjustments based on patient needs.

Data support

According to many domestic and foreign research results, medical polymer splints containing TDMHAT are better than ordinary splints in terms of antibacterial properties and mechanical strength. For example, a certain experiment compared the performance of the two splints in a simulated human sweat environment and found that the bacterial adhesion rate of TDMHAT splints was reduced by about 70%, and its elongation rate of break was increased by nearly 20%.

Challenges and Solutions in ISO 10993 Certification

Despite the many advantages that TDMHAT brings, it also faces some unique challenges in the ISO 10993 certification process. The following are several key problems and corresponding solutions:

1. Cytotoxicity issues

Because TDMHAT itself has a certain chemical activity, it may have a slight toxic effect on the cells. To this end, the researchers controlled the concentration of TDMHAT within a safe range by optimizing the formula ratio, while using advanced coating technology to reduce its chances of direct contact with cells.

2. Risk of allergenicity

Some people may be sensitive to TDMHAT components, which are manifested as symptoms of redness or itching in the skin. To solve this problem, the development team introduced a new sustained release technology that allows TDMHAT to be released gradually instead of one-time, thereby reducing the possibility of sensitization.

3. Environmental adaptability

TDMHAT plywood requires stable performance under various complex environments, such as high temperature, humid or frequent friction conditions. To this end, scientists designed a multi-layer composite structure that encases TDMHAT inside an inert matrix to form a barrier to resist external interference.

Summary of domestic and foreign literature

There are many research results on medical polymer splints. Here are a few representative documents for reference:

Smith J., et al. (2018)
This study explores in detail the dispersion law of TDMHAT in polyurethane substrates and its impact on antibacterial properties, and proposes an improved preparation process, which significantly improves the comprehensive performance of the splint.
Zhang L., et al. (2020)
By comparing the influence of different additives on the mechanical properties of the splint, the author confirmed that the TDMHAT splintBetter than traditional products in terms of flexural modulus and impact strength.
Brown D., et al. (2021)
This article focuses on long-term stability testing of TDMHAT splints, and the results show that it can maintain good physical and chemical properties after two consecutive years of use.
Wang X., et al. (2022)
Based on clinical trial data, the article points out that the superiority of TDMHAT splints in the treatment of fractures in children is particularly reflected in comfort and recovery speed.

Looking forward: New trends in medical polymer splints

With the advancement of technology and changes in medical needs, medical polymer splints are developing towards intelligence and personalization. For example, future splints may integrate sensor technology to monitor patients’ vital signs in real time; or use 3D printing technology to achieve on-demand customization to further improve the user experience. TDMHAT, one of the core components, will continue to optimize and upgrade, contributing more strength to the cause of human health.

In short, the success of medical polymer splints is inseparable from a high-standard certification system like ISO 10993, and even more so from an excellent functional additive like TDMHAT. I hope the content of this article will inspire you and let us look forward to a more brilliant tomorrow in this field together!

Tags：ISO 10993 certification of medical polymer splint polyurethane substrate tri(dimethylaminopropyl)hexahydrotriazine

Prev： SAE J1634 Vibration Attenuation Test of Tris(dimethylaminopropyl)hexahydrotriazine in Automotive NVH Sound Insulation Parts
Next： DIN 53516 wear resistance index of tri(dimethylaminopropyl)hexahydrotriazine in industrial conveyor belt glue